HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome.

Abstract
In view of reported delayed clearance of 51Cr labelled IgG sensitized autologous erythrocytes in systemic lupus erythematosus, we measured clearance half-time (t1/2) in 16 patients with the drug induced lupus erythematosus syndrome. The mean t1/2 for the patients with drug induced lupus was 52 min, and for 16 normals mean was 48 min, a difference without statistical significance. Nine of the patients with drug induced lupus had laboratory abnormalities only, and mean t1/2 in this group was not significantly different from that in the 7 symptomatic patients. T1/2 was not significantly associated with Clq or DNA binding levels in symptomatic or asymptomatic patients. Normal mean clearance of model immune complexes was thus present in patients with drug induced lupus, with and without symptoms, and may protect against renal and central nervous system disease in drug induced lupus erythematosus.
AuthorsT R Fields, M H Zarrabi, E N Gerardi, R S Bennett, S Zucker, M I Hamburger
JournalThe Journal of rheumatology (J Rheumatol) Vol. 13 Issue 4 Pg. 726-31 (Aug 1986) ISSN: 0315-162X [Print] Canada
PMID3772920 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigen-Antibody Complex
  • Autoantibodies
  • Immunoglobulin G
  • Receptors, Fc
  • DNA
  • Chlorpromazine
Topics
  • Adult
  • Aged
  • Antigen-Antibody Complex (analysis)
  • Autoantibodies (analysis)
  • Chlorpromazine (adverse effects)
  • DNA (immunology)
  • Erythrocytes (immunology)
  • Female
  • Humans
  • Immunoglobulin G (immunology)
  • Lupus Erythematosus, Systemic (chemically induced, immunology)
  • Male
  • Middle Aged
  • Mononuclear Phagocyte System (immunology)
  • Receptors, Fc (immunology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: